Page 6 - Pascal Nigen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Helix BioPharma Corp. Announces Institutional Investment for Gross Proceeds of up to CAD$10 million RICHMOND HILL, ON / ACCESSWIRE / May 11, 2021 / Helix BioPharma Corp.(TSX:HBP)("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has entered into a definitive convertible security funding agreement (the "Agreement") with Lind Global Macro Fund, LP, a New York based institutional investment fund managed by The Lind Partners, LLC (together, "Lind"). Under the terms of the Agreement, an in...

Doré Copper Mining to Present at Alpha Bronze Virtual Town Hall NEW YORK, NY / ACCESSWIRE / April 13, 2021 / Alpha Bronze, LLC ("Alpha Bronze"), is pleased to announce that Doré Copper Mining (TSXV:DCMC)(OTCQB:DRCMF) ("Doré Copper" or the "Company"), a copper-gold explorer and developer in the Chibougamau area of Québec, will be presenting at Alpha Bronze Virtual Town Hall on Wednesday, April 14, 2021 at 12:00 PM ET. Mr. Ernest Mast, Chief Executive Officer of Doré Copper will give an overview of the Company, its hub-and-spoke development strategy built on advancing its high-grade copper...

Press release content from Accesswire. The AP news staff was not involved in its creation. Helix BioPharma Corp. Announces Fiscal Second Quarter 2021 Results March 16, 2021 GMT RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX:"HBP"), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second ... RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX:"HBP"), an immuno-oncology company developing drug candidates for the prevention and treatment of ...

Tetra Bio-Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference OTTAWA, ON / ACCESSWIRE / March 3, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development announces that CEO Dr. Guy Chamberland will present a company overview and hold virtual investor meetings at the H.C. Wainwright Global Life Sciences Virtual Conference being held March 9-10, 2021. The Tetra Bio-Pharma webcast presentation can be accessed by registering for the H.C. Wainwright Global Life Science...

Company signs LOI for Nordics and Germany OTTAWA, ON / ACCESSWIRE / February 25, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a biopharmaceutical pioneer in immunomodulator